Evan Ya-Wen
Yu
M.D.
(206) 606-1943
Fred Hutchinson Cancer Center
825 Eastlake Ave. E, LG-465
Seattle, WA 98109
Photo: Fred Hutch
Education, Training, Board Certifications
- M.D., University of Washington, School of Medicine
- Residency, Brigham and Women’s Hospital, Internal Medicine
- Fellowship in Hematology and Oncology, Dana Farber Cancer Institute
- Medical Oncology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Clinical Expertise
- Genitourinary cancers
- Prostate cancer
- Bladder cancer
- Testicular cancer
Affiliations
- University of Washington
- Fred Hutchinson Cancer Center - Faculty & Lab
- Fred Hutchinson Cancer Center - Provider
Publications
Research and/or clinical interests
Dr. Evan Y. Yu is a medical oncologist specializing in prostate, bladder, and testicular cancer treatment and research. Dr. Yu is the Clinical Research Director for GU malignancies, Core Director for the Pacific Northwest Prostate Cancer SPORE and co-PI of the DoD Prostate Cancer Clinical Trials Consortium for his institution. He is the institution's Principal Investigator for the National Cancer Trials Network Lead Academic Performance Site (LAPS) Grant, SWOG, and ECOG/ACRIN. His research focuses on testing the next wave of novel molecular targeted therapies and immunotherapy techniques, with a complementary focus on imaging biomarkers. In addition to an active clinical and research practice, he also is the Medical Director for Clinical Research Services at the Fred Hutchinson Cancer Consortium. He has regularly been voted a “Top Doctor” by Castle Connolly, U.S. News and World Report, Seattle magazine, and Seattle Met magazine. He has served for many years on the National Cancer Institute Genitourinary Cancers Steering Committee and is the Co-Chair for the National Cancer Institute Prostate Cancer Task Force. Dr. Yu has held various roles within ASCO, AACR and also serves as a senior editor for Clinical Cancer Research and Uro-Today.